Home Cart Sign in  
Chemical Structure| 506-37-6 Chemical Structure| 506-37-6

Structure of Nervonic acid
CAS No.: 506-37-6

Chemical Structure| 506-37-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Nervonic acid is a monounsaturated fatty acid important in the biosynthesis of myelin. It is enriched in sphingomyelin and may enhance the brain functions and prevent demyelination.

Synonyms: Selacholeic acid; cis-15-Tetracosenoic acid; Nervonic acid (cis-15)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Nervonic acid

CAS No. :506-37-6
Formula : C24H46O2
M.W : 366.62
SMILES Code : CCCCCCCC/C=C\CCCCCCCCCCCCCC(O)=O
Synonyms :
Selacholeic acid; cis-15-Tetracosenoic acid; Nervonic acid (cis-15)
MDL No. :MFCD00010507
InChI Key :GWHCXVQVJPWHRF-KTKRTIGZSA-N
Pubchem ID :5281120

Safety of Nervonic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293 cells 1 µM 24 hours To investigate the effect of nervonic acid on C24:1-ceramide levels after CerS2 knockdown. Results showed that nervonic acid partially restored C24:1-ceramide levels. FASEB J. 2020 Nov;34(11):15314-15326
RSC96 cells 0-200 µM 24 hours To evaluate the protective effect of nervonic acid on RSC96 cells under oxidative stress. Results showed that nervonic acid was not cytotoxic to RSC96 cells at concentrations of 0–200 μM and exhibited protective effects under 150–200 μM H2O2. Front Pharmacol. 2024 Oct 22;15:1487183
PC12 cells 0-200 µM 24 hours To evaluate the protective effect of nervonic acid on PC12 cells under oxidative stress. Results showed that nervonic acid was not cytotoxic to PC12 cells at concentrations of 0–200 μM and exhibited protective effects under 80–125 μM H2O2. Front Pharmacol. 2024 Oct 22;15:1487183
Human adipose-derived mesenchymal stem cells (AD-MSCs) 40-280 µM 3 or 7 days To assess the effect of nervonic acid on adipogenic differentiation of AD-MSCs. Results showed that NA treatment accelerated adipogenesis through activation of the Akt/mTOR pathway and inhibition of Wnt signaling. Int J Mol Med. 2024 Dec;54(6):108
Normal (NHDF) fibroblasts 5, 20, 50 µM 5 days Nervonic acid significantly decreased the levels of total saturated VLCFA but had no further effect on C26:0 levels. Neurotherapeutics. 2022 Apr;19(3):1007-1017
CALD (GM04904) fibroblasts 5, 20, 50 µM 5 days Nervonic acid significantly decreased the intracellular accumulation of total lipid C26:0 and total saturated VLCFA in a concentration-dependent manner. Neurotherapeutics. 2022 Apr;19(3):1007-1017
AMN (GM17819) fibroblasts 5, 20, 50 µM 5 days Nervonic acid significantly decreased the intracellular accumulation of total lipid C26:0 and total saturated VLCFA in a concentration-dependent manner. Neurotherapeutics. 2022 Apr;19(3):1007-1017

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Diet-induced obesity model Dietary supplementation 0.6% (6 g/kg diet) 12 weeks To investigate the effect of nervonic acid on high-fat diet-induced obesity and related metabolic parameters. Results showed that nervonic acid supplementation reduced weight gain and adiposity, improved glycemic control and insulin sensitivity, and increased PPARα and PGC1α expression in the liver. FASEB J. 2020 Nov;34(11):15314-15326
C57BL/6J mice Radiation-induced lung injury model Oral gavage 100 mg/kg Every other day until the end of the observation period To investigate the protective effect of nervonic acid on radiation-induced lung injury, results showed that NA could alleviate lung tissue inflammation, regulate changes in macrophage subsets, and reduce inflammatory factor levels. Front Immunol. 2024 Dec 11;15:1405020
C57BL/6 mice Fat transplantation model Subcutaneous injection 160 µM Single administration, lasting for 5 weeks To evaluate the effect of nervonic acid on fat transplantation outcomes. Results showed that NA treatment reduced the resorption of transplanted fat, increased the proportion of perilipin-1+ adipocytes, reduced inflammation, and promoted angiogenesis. Int J Mol Med. 2024 Dec;54(6):108
Rats Middle cerebral artery occlusion (MCAO) model Irrigation 480 mg/kg 5 days To evaluate the therapeutic effects of nervonic acid on cerebral ischemia-reperfusion injury. Results showed that NA significantly mitigated brain and neuronal damage, improved neurological function scores, and reduced cerebral infarction area. Front Cell Dev Biol. 2025 Jan 28;13:1546073
Sprague-Dawley rats Skin nerve injury model Topical administration 5 mg/mL and 25 mg/mL Every other day for 18 days To evaluate the effect of nervonic acid on wound healing in rats. Results showed that nervonic acid treatment significantly improved wound healing rate, expression of nerve regeneration markers (NF-200 and S100), and angiogenesis markers (CD31 and VEGF) compared to the control group. Front Pharmacol. 2024 Oct 22;15:1487183

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.73mL

0.55mL

0.27mL

13.64mL

2.73mL

1.36mL

27.28mL

5.46mL

2.73mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories